Chemopreventive actions of polyphenolic compounds in cancer

Muhammad A Soobrattee1, Theeshan Bahorun, Okezie I Aruoma

  • 1Department of Biosciences, Faculty of Science, University of Mauritius, Réduit, Republic of Mauritius.

Insights

Phenolic compounds in fruits and vegetables may prevent cancer by acting as antioxidants and modulating cell signaling pathways. These bioactive compounds also play a role in preventing gap junction intercellular communication, crucial in cancer prevention.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Oxidative stress, inflammation, and aberrant cell signaling contribute to chronic diseases like cancer.
  • Dietary intake of fruits, vegetables, and teas is linked to reduced cancer incidence.
  • Phenolic compounds are key bioactive constituents in these foods, known for antioxidant properties.

Purpose of the Study:

  • To review the chemopreventive potential of phenolic compounds.
  • To focus on the role of phenolics in modulating cell signaling pathways.
  • To examine the impact of phenolics on gap junction intercellular communication in cancer prevention.

Main Methods:

  • Literature review of scientific studies on phenolics, oxidative stress, and cancer.
  • Analysis of research on cell signaling pathways and their modulation by phenolics.
  • Investigation of studies related to gap junction intercellular communication and cancer.

Main Results:

  • Phenolics exhibit antioxidant and free radical scavenging activities.
  • Emerging evidence suggests phenolics modulate cell signaling pathways involved in cancer.
  • Phenolics may prevent cancer by influencing gap junction intercellular communication.

Conclusions:

  • Phenolic compounds possess significant chemopreventive properties.
  • Modulation of cell signaling pathways is a key mechanism for phenolic chemoprevention.
  • Targeting gap junction intercellular communication by phenolics offers a novel strategy for cancer prevention.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...